Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
Guidance Documents/Guidance-Document/Presenting Risk Information in Prescription Drug and Medical Device Promotion

Presenting Risk Information in Prescription Drug and Medical Device Promotion

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

May 27, 2009

February 9, 2019

Center for Drug Evaluation and Research

85abd709-63d2-4514-8e97-a628a63a8b2e

Related Documents

Malaria: Developing Drugs for Treatment: Draft Guidance for Industry

Guidance DocumentSeptember 23, 2025Center for Drug Evaluation and Research
View Details →

Certification Process of Designated Medical Gases

Guidance DocumentNovember 25, 2015Center for Drug Evaluation and Research
View Details →

Pharmacogenomic Data Submissions — Companion Guidance

Guidance DocumentAugust 28, 2007Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.